Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
DRUG PRODUCT COMPOSITIONS
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. 183204-72-0
2. Tipiracil Hcl
3. Tipiracil (hydrochloride)
4. Tipiracil Hydrochloride [usan]
5. Tas-1-462
6. 4h59klq0a4
7. 5-chloro-6-((2-iminopyrrolidin-1-yl)methyl)pyrimidine-2,4(1h,3h)-dione Hydrochloride
8. Chembl65375
9. Ma-1 Hydrochloride
10. Tpi
11. Unii-4h59klq0a4
12. Tipiracil.hcl
13. 5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]pyrimidine-2,4(1h,3h)-dione Hydrochloride
14. Tipiracilhydrochloride
15. Tipiracil Monohydrochloride
16. 5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]-1h-pyrimidine-2,4-dione;hydrochloride
17. Schembl1682924
18. Chebi:90877
19. Ex-a882
20. Dtxsid001027748
21. Amy25415
22. Bcp06245
23. Ex-a1393
24. Hy-a0063
25. Tipiracil Hydrochloride (jan/usan)
26. Tipiracil Hydrochloride [mi]
27. Mfcd01571384
28. S3731
29. Tipiracil Hydrochloride [jan]
30. Akos027427002
31. Ccg-267234
32. Cs-1637
33. Tipiracil Hydrochloride [who-dd]
34. 2,4(1h,3h)-pyrimidinedione,5-chloro-6-[(2-imino-1-pyrrolidinyl)methyl]-, Hydrochloride (1:1)
35. Ac-30634
36. As-56082
37. Tipiracil Hydrochloride, >=98% (hplc)
38. Db-065426
39. Ft-0700247
40. Tipiracil Hydrochloride [orange Book]
41. A13098
42. D10467
43. Lonsurf Component Tipiracil Hydrochloride
44. A847265
45. S-95005 Component Tipiracil Hydrochloride
46. Tas-102 Component Tipiracil Hydrochloride
47. Tipiracil Hydrochloride Component Of Lonsurf
48. J-690251
49. Q27162848
50. 5-chloro-6-(1-(2-iminopyrrolidinyl)methyl)uracil Hydrochloride
51. 5-chloro-6-(1-(2-iminopyrrolidinyl)-methyl)uracil Hydrochloride
52. 2,4(1h,3h)-pyrimidinedione,5-chloro-6-[(2-imino-1-pyrrolidinyl)methyl] Hydrochloride
53. 5-chloro-6-((2-iminopyrrolidin-1-yl)methyl)pyrimidine-2,4(1h,3h)-dione Hcl
54. 5-chloro-6-((2-iminopyrrolidin-1-yl)methyl)pyrimidine-2,4(1h,3h)-dionehydrochloride
55. 5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1h,3h)-pyrimidinedione Hydrochloride
56. 5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4-(1h,3h)-pyrimidinedione Hydrochloride
57. 1-[(5-chloro-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)methyl]pyrrolidin-2-iminium Chloride
58. 2,4(1h,3h)-pyrimidinedione, 5-chloro-6-((2-imino-1-pyrrolidinyl)methyl)-, Hydrochloride (1:1)
59. 5-chloro-6-((2-iminopyrrolidin-1-yl)methyl)pyrimidine-2,4(1h,3h)-dione Hydrochloride;tipiracil Hcl
60. 5-chloro-6-(2-imino-pyrrolidin-1-yl)methyl-2,4(1h,3h)-pyrimidinedione Hydrochloride
| Molecular Weight | 279.12 g/mol |
|---|---|
| Molecular Formula | C9H12Cl2N4O2 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 278.0337310 g/mol |
| Monoisotopic Mass | 278.0337310 g/mol |
| Topological Polar Surface Area | 85.3 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 404 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33217
Submission : 2018-09-28
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-05-28
Pay. Date : 2019-04-22
DMF Number : 33787
Submission : 2019-04-18
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36239
Submission : 2023-11-20
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2019-04-12
Pay. Date : 2019-02-14
DMF Number : 33578
Submission : 2019-02-19
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2019-09-04
Pay. Date : 2019-04-15
DMF Number : 33639
Submission : 2019-03-02
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2019-09-19
Pay. Date : 2019-09-16
DMF Number : 33534
Submission : 2019-01-31
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2019-09-25
Pay. Date : 2019-07-25
DMF Number : 33926
Submission : 2019-08-08
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28368
Submission : 2014-11-25
Status : Active
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
21
PharmaCompass offers a list of Tipiracil Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tipiracil Hydrochloride manufacturer or Tipiracil Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tipiracil Hydrochloride manufacturer or Tipiracil Hydrochloride supplier.
PharmaCompass also assists you with knowing the Tipiracil Hydrochloride API Price utilized in the formulation of products. Tipiracil Hydrochloride API Price is not always fixed or binding as the Tipiracil Hydrochloride Price is obtained through a variety of data sources. The Tipiracil Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tipiracil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tipiracil, including repackagers and relabelers. The FDA regulates Tipiracil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tipiracil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tipiracil manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tipiracil supplier is an individual or a company that provides Tipiracil active pharmaceutical ingredient (API) or Tipiracil finished formulations upon request. The Tipiracil suppliers may include Tipiracil API manufacturers, exporters, distributors and traders.
click here to find a list of Tipiracil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tipiracil DMF (Drug Master File) is a document detailing the whole manufacturing process of Tipiracil active pharmaceutical ingredient (API) in detail. Different forms of Tipiracil DMFs exist exist since differing nations have different regulations, such as Tipiracil USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tipiracil DMF submitted to regulatory agencies in the US is known as a USDMF. Tipiracil USDMF includes data on Tipiracil's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tipiracil USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tipiracil suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Tipiracil Drug Master File in Korea (Tipiracil KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Tipiracil. The MFDS reviews the Tipiracil KDMF as part of the drug registration process and uses the information provided in the Tipiracil KDMF to evaluate the safety and efficacy of the drug.
After submitting a Tipiracil KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Tipiracil API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Tipiracil suppliers with KDMF on PharmaCompass.
A Tipiracil written confirmation (Tipiracil WC) is an official document issued by a regulatory agency to a Tipiracil manufacturer, verifying that the manufacturing facility of a Tipiracil active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Tipiracil APIs or Tipiracil finished pharmaceutical products to another nation, regulatory agencies frequently require a Tipiracil WC (written confirmation) as part of the regulatory process.
click here to find a list of Tipiracil suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tipiracil as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tipiracil API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tipiracil as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tipiracil and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tipiracil NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tipiracil suppliers with NDC on PharmaCompass.
Tipiracil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tipiracil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tipiracil GMP manufacturer or Tipiracil GMP API supplier for your needs.
A Tipiracil CoA (Certificate of Analysis) is a formal document that attests to Tipiracil's compliance with Tipiracil specifications and serves as a tool for batch-level quality control.
Tipiracil CoA mostly includes findings from lab analyses of a specific batch. For each Tipiracil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tipiracil may be tested according to a variety of international standards, such as European Pharmacopoeia (Tipiracil EP), Tipiracil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tipiracil USP).